Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-11-011862
Filing Date
2011-08-08
Accepted
2011-08-08 16:16:19
Documents
1
Period of Report
2011-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3296
  Complete submission text file 0001179110-11-011862.txt   4688
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Issuer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 360 MOUNT KEMBLE AVENUE MORRISTOWN NJ 07960
Business Address
Menard Francois A (Reporting) CIK: 0001426166 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13305 | Film No.: 111017393